Sector: Health Care
Director information for CVS HEALTH CORP (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Alecia A. DeCoudreaux | President Emerita of Mills College at Northeastern University and Former Executive at Eli Lilly and Company; Independent Director | 71 | ["President Emerita of Mills College at Northeastern University", "Former Executive at Eli Lilly and Company", "More than 30 years of experience in the pharmaceutical industry", "Expertise in corporate governance", "Experience in state and federal government relations", "Focus on community relations"] | ["HS&T", "N&CG", "Health Services and Technology", "Nominating and Corporate Governance", "Health Services and Technology Committee"] | 2026 |
| Anne M. Finucane | Chair of the Board of Rubicon Carbon and Former Vice Chairman of Bank of America Corporation; Independent Director | 73 | ["Chair of the Board of Rubicon Carbon", "Former Vice Chairman of Bank of America Corporation", "Senior Advisor of the TPG Climate Rise Fund", "Experience in regulated financial services industry", "Consumer strategies and marketing expertise", "Public policy and government affairs knowledge"] | ["MP&D", "PP&EA (Chair)", "E", "Management Planning and Development", "Public Policy and External Affairs", "Executive"] | 2026 |
| C. David Brown II | Partner and Former Member of Executive Committee of Nelson Mullins Riley & Scarborough LLP; Independent Director | 74 | ["Partner and Former Member of the Executive Committee of Nelson Mullins Riley & Scarborough LLP", "Legal expertise and health care experience", "Ability to analyze and interpret complex issues", "Experience in large-scale corporate and real estate transactions", "Health care oversight experience through UF Health", "Experience with Orlando Health board and executive committee"] | ["MP&D (Chair)", "N&CG", "PP&EA", "Management Planning and Development (Chair)", "Nominating and Corporate Governance", "Public Policy and External Affairs"] | 2026 |
| David Joyner | Chair | [] | [] | 2026 | |
| Douglas H. Shulman | Chairman and CEO of OneMain Holdings, Inc.; Chairman and Chief Executive Officer | 58 | ["Chief Executive Officer of OneMain Holdings, Inc.", "Senior Executive Vice President at BNY Mellon", "Senior Advisor at McKinsey & Company", "Commissioner of the Internal Revenue Service", "Vice Chairman at FINRA", "President of Markets, Services and Information at FINRA"] | ["HS&T", "MP&D", "Health Services and Technology", "Management Planning and Development", "Health Services and Technology Committee"] | 2026 |
| Fernando Aguirre | Former Chairman, President and CEO of Chiquita Brands International, Inc.; Director | 68 | ["Former Chairman, President and CEO of Chiquita Brands International, Inc.", "More than 23 years in brand management, general management and turnarounds at The Procter & Gamble Company", "Significant brand management and international experience"] | ["A (Chair)", "MP&D", "Audit (Chair)", "Management Planning and Development"] | 2026 |
| Guy P. Sansone | Chairman and CEO of H2 Health; Independent Director | 61 | ["Co-Founder, Chairman and Chief Executive Officer of H2 Health", "Managing Director at Alvarez & Marsal", "Member of the board of directors of several publicly traded and privately held health care companies", "Experience in health care industry", "Public company audit committee member", "Expertise in finance"] | ["A", "N&CG", "Audit", "Nominating and Corporate Governance"] | 2026 |
| J. David Joyner | President, CEO and Chair of the Board of CVS Health Corporation; President, Chief Executive Officer and Chair of the Board | 61 | ["Nearly 40 years of health care and pharmacy benefit management experience", "Chief Executive Officer and President of CVS Health since October 17, 2024", "Executive Vice President and President of Pharmacy Services since January 2023", "Advisory Council member of the Rawls College of Business at Texas Tech University since July 2020", "Various roles at CVS Health and predecessors including Executive Vice President \u2013 Sales and Account Services"] | ["PP&EA", "E (Chair)", "Executive", "Public Policy and External Affairs"] | 2026 |
| Jeffrey Balser | Chair | [] | ["Health Services and Technology Committee"] | 2026 | |
| Jeffrey R. Balser, M.D, Ph.D. | [] | [] | 2026 | ||
| Jeffrey R. Balser, M.D., Ph.D. | President and CEO of Vanderbilt University Medical Center; President and Chief Executive Officer | 64 | ["Chief executive of Vanderbilt University Medical Center since 2009", "President and Chief Executive Officer since 2016", "Dean of the Vanderbilt University School of Medicine since 2008", "Elected member of the National Academy of Medicine", "Served on the board of Varian Medical Systems, Inc.", "Expertise in large regional quaternary health delivery system leadership", "Human capital management", "Senior business management experience", "Overall risk management expertise", "Financial expertise", "Leading NIH-funded research in pharmacogenomics", "Experience in personalized medicine and health information technology"] | ["A", "HS&T (Chair)", "E", "Health Services and Technology", "Audit", "Executive"] | 2026 |
| John E. Gallina | Former Executive Vice President and Chief Financial Officer of Elevance Health, Inc.; Independent Director | 66 | ["Former Executive Vice President and Chief Financial Officer of Elevance Health, Inc.", "Over 40 years of financial and business management experience", "Extensive financial leadership experience overseeing finance and actuarial functions", "Deep understanding of the health insurance industry", "Experience with audit-related issues"] | ["A", "Audit"] | 2026 |
| J. Scott Kirby | CEO and a Member of the Board of United Airlines Holdings, Inc.; Chief Executive Officer and Member of the Board | 58 | ["Business Development and Corporate Transactions", "Regulated Industries", "Finance", "Senior Leadership", "Public Policy and Government Affairs", "Technology and Innovation"] | ["HS&T", "N&CG", "Health Services and Technology", "Nominating and Corporate Governance"] | 2026 |
| Larry M. Robbins | Founder, CEO and Portfolio Manager of Glenview Capital Management, LLC; Independent Director | 56 | ["Founder and Chief Executive Officer of Glenview Capital Management, LLC", "30 years of experience as a portfolio manager", "Expertise in health care industry", "Experience in financial reporting and controls, capital allocation and markets strategy", "Lead independent director of Butterfly Network, Inc."] | ["A", "PP&EA", "Audit", "Public Policy and External Affairs"] | 2026 |
| Leslie V. Norwalk | Strategic Counsel at Epstein Becker & Green P.C.; Director | 60 | ["Strategic Counsel at Epstein, Becker & Green, P.C.", "Advises companies through EBG Advisors", "Advisor to private equity investors", "Former Acting Administrator for the U.S. Centers for Medicare & Medicaid Services", "Deep knowledge of the health care industry and related government regulations", "Experience with corporate governance, health care compliance and risk management", "extensive expertise in health care", "former Acting Administrator of CMS"] | ["HS&T", "PP&EA", "Health Services and Technology", "Public Policy and External Affairs", "Health Services and Technology Committee"] | 2026 |
| Michael F. Mahoney | Chairman of the Board, President and CEO of Boston Scientific Corporation; Chairman, President and CEO of Boston Scientific Corporation | 61 | ["Extensive experience leading global medical products companies", "Expertise in building strong leadership teams", "Developing international markets", "Proven ability to execute successful business strategies and drive operational excellence", "Significant knowledge of the global medical products business"] | ["MP&D", "N&CG (Chair)", "E", "Management Planning and Development", "Nominating and Corporate Governance", "Executive"] | 2026 |
| Roger N. Farah | [] | [] | 2026 | ||
| Scott Kirby | [] | ["Health Services and Technology Committee"] | 2026 |
